Serum prostate-specific antigen, radiologic findings and Gleason score in prostate biopsies in Jordan

Smith, 2001, American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001-Testing for Early Lung Cancer Detection, CA Cancer J Clin., 51, 38, 10.3322/canjclin.51.1.38 Haas, 1997, Epidemiology of prostate cancer, CA Cancer J Clin., 47, 273, 10.3322/canjclin.47.5.273 Center, 2001 Ries, 2000 Catalona, 1991, Measurement of prostate-specific antigen in serum as a screening test for prostate cancer, N Engl J Med., 324, 1156, 10.1056/NEJM199104253241702 Brawer, 1992, Screening for prostatic carcinoma with prostate specific antigen, J Urol., 147, 841, 10.1016/S0022-5347(17)37401-3 Kuriyama, 1980, Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay, Cancer Res., 40, 4658 Brosman von Eschenbach, 1997, N. American Cancer Society guideline for the early detection of prostate cancer: update 1997, CA Cancer J Clin., 47, 261, 10.3322/canjclin.47.5.261 Catalona, 1997, Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0ng/mL and benign prostate examination: enhancement of specificity with free PSA measurements, JAMA, 277, 1452, 10.1001/jama.1997.03540420048028 Babaian, 2001, The incidence of prostate cancer in a screening population with a serum prostate specific antigen between 2.5 and 4.0ng/mL: relation to biopsy strategy, J Urol., 165, 757, 10.1016/S0022-5347(05)66519-6 Thompson, 2004, Prevalence of prostate cancer among men with a prostate specific antigen level <4.0ng/mL, N Engl J Med., 350, 2239, 10.1056/NEJMoa031918 Shetty Barry, 2004, Prostate-specific antigen testing for early diagnosis of prostate cancer, N Engl J Med., 344, 1373, 10.1056/NEJM200105033441806 Benson, 1992, Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer, J Urol., 147, 815, 10.1016/S0022-5347(17)37393-7 Moul, 2005, Genitourinary malignancies: Prostate cancer Lee, 1989, The role of transrectal ultrasound in the early detection of prostate cancer, CA Cancer J Clin., 39, 337, 10.3322/canjclin.39.6.337 Moul, 1999, Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients, J Urol, 162, 394, 10.1016/S0022-5347(05)68568-0 Oesterling, 1995, Serum prostate specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men, Br J Urol., 75, 347, 10.1111/j.1464-410X.1995.tb07347.x Fowke, 2006, Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian Men, Cancer., 107, 2361, 10.1002/cncr.22249 Grunkemeier, 2006, Predicting prostate biopsy results: The importance of PSA, age and race, Am J Clin Pathol, 126, 110, 10.1309/PXV2VMB32EC789DA Tanguay, 2000 Sheth, 1991, Stage A adenocarcinoma of the prostate: transrectal US and sonographic- pathologic correlation, Radiol., 179, 35, 10.1148/radiology.179.1.2006300 Lee, 1989, Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen, Radiology., 170, 29, 10.1148/radiology.170.1.2462262 Clements, 2001, Ultrasound of prostate cancer, Eur Radiol., 11, 2119, 10.1007/s003300101028